Gigantic subcutaneous lipoma – A case report  by Lang, Christian Lyngsaa et al.
JPRAS Open 3 (2015) 6e9Contents lists available at ScienceDirect
JPRAS Open
journal homepage: ht tp: / /www. journals .e lsevier .com/
jpras-openCase report
Gigantic subcutaneous lipoma e A case report
Christian Lyngsaa Lang a, *, Christine Schmidt Andersen b, Grethe Schmidt a,
Christian Bonde a
a Department of Plastic Surgery, Breast Surgery and Burns Treatment, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen, Denmark
b Health, Aarhus University, Nordre Ringgade 1, 8000 Aarhus C, Denmarka r t i c l e i n f o
Article history:
Received 21 November 2014
Accepted 1 December 2014
Available online 10 December 2014
Keywords:
Lipoma
Axilla
Surgery
Giant* Corresponding author. Sortedam Dossering 53c
E-mail address: c.lyngsaa@gmail.com (C.L. Lang
http://dx.doi.org/10.1016/j.jpra.2014.12.001
2352-5878/© 2014 The Authors. Published by Elsevi
Surgeons. This is an open access article under the Cs u m m a r y
Lipomas are the most common benign mesenchymal tumour. The
solitary subcutaneous lipoma accounts for approximately one-
quarter to one-half of all soft tissue tumours. The preferred loca-
tions include the trunk, shoulder, upper arm, and the neck. In this
case report, we present a gigantic axillary lipoma weighing
23.35 kg. Due to the tumour mass and its long-term presence, the
lipoma caused anatomical changes in the axilla making its removal
challenging and difﬁcult.
© 2014 The Authors. Published by Elsevier Ltd on behalf of British
Association of Plastic, Reconstructive and Aesthetic Surgeons. This
is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/3.0/).Introduction
Lipomas are the most common benign mesenchymal tumour. Lipomas have an estimated preva-
lence rate of 2.1 per 1000 people. The solitary subcutaneous lipoma accounts for approximately one-
quarter to one-half of all soft tissue tumours.1 They can occur as either solitary or multiple tumours
located in almost any organ of the human body. The preferred locations include the trunk, shoulder,
upper arm and the neck. The largest subcutaneous lipoma ever reported was published by Brandler in
British Medical Journal (BMJ) in 1894. A 22.7-kg lipomawas removed from the left scapula of a 26-year-
old male patient. In this study, we present a 62-year-old male patient with a giant axillary lipoma. The
tumour had a total weight of 23.35 kg. It had been present for approximately 35 years. The case is of
interest due to the size, location, anatomical changes and surgical challenge.1.-1, 2100 Copenhagen, Denmark. Tel.: þ45 40930858.
).
er Ltd on behalf of British Association of Plastic, Reconstructive and Aesthetic
C BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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A 62-year-old man, without any previous contact with the health-care system, consulted his general
practitioner (GP) due to symptoms of shortness of breath andpalpitations. Thepatientwas referred to the
local hospital, andhewasdiagnosedwith atrialﬁbrillation.However, thephysical examination revealed a
giant tumour in the right axilla. The tumour had not been present at childhood, but it had grown
increasingly larger in the last 30e35 years and it measured approximately 50  30 cm (Figure 1). The
patientwasunable toﬁt insideamagnetic resonance imaging (MRI) scanner, due to the size of the lipoma.
Computed tomography imaging (CTI) of the thorax and abdomen was performed. The tumour was
diagnosed as a giant lipoma. Themajority of the lipomawas localised in the axilla, but a smaller portion of
the lipoma extended to the right upper arm, reaching the elbow. In accordance with his wishes, the
patient underwent surgery at the local hospital. Unfortunately, the surgeon was unable to remove the
entiremass of the lipomadue to close relation of the axillary vessels andnerves. The patientwas referred
to the Copenhagen University Hospital, Rigshospitalet. An MRI scan could now be performed, and the
patient underwent surgeryagain. A total lipomamass of 23.35 kgwas removed.Due to itsmassiveweight
and long-term presence, the lipoma had displaced the brachial plexus 20 cm distal to the axilla, hence
obscuring normal anatomy. The neurovascular bundlewas found to be inﬁltrated and surrounded by the
lipoma. The medial, lateral and posterior cord of the brachial plexus also showed signs of lipomatous
proliferation (Figure 2). Theseﬁndingswerenot detectedby theMRI presumably due to previous surgery.
The remaining part of the lipoma was not removed due to the risk of nerve damage.
Histopathological examination revealed a simple subcutaneous lipoma. There were no signs of
liposarcoma transformation.
Discussion
Lipomas are often small, and most have a diameter <2 cm. They rarely grow larger than 10 cm.2 A
lipoma is categorised as ‘giant’ when it reaches a weight of at least 1000 g or a diameter more thanFigure 1. Picture taken with a mobile phone prior to initial surgery summer 2012.
Figure 2. The displaced medial, lateral and posterior cord of the brachial plexus with signs of lipomatous proliferation.
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altered sensation resulting from compression of neighbouring structures.4 Many seek treatment
because of social embarrassment or the inability to hide the tumour from society.
The aetiology of lipomas is unknown. They can be sporadic or part of an inherited disease such as
familial multiple lipomatosis.5 Traumas have been reported to cause lipomas due to rupture of the
ﬁbrous septae inducing adipose tissue migration and proliferation.
Although lipoma is often a benign neoplasm, the likely transformation to liposarcomas is well
known. Rydholm et al. concluded that a tumour larger than 5 cm, located either in the thigh or sub-
fascially, is relatively more likely to be a sarcoma.1 These criteria may be useful in the selection of
patients who should be referred to a tumour centre preoperatively. A deﬁnitive diagnosis can only be
made by histopathological examination, but ultrasonography, CTI or MRI can help categorise the
tumour. The latter set of diagnoses, being the gold standard, should be performed preoperatively in
accordance with national Danish guidelines regarding sarcomas.
The primary treatment is surgery. Suction-assisted lipectomy through small incisions is preferred
by some surgeons due to a superior aesthetic outcome and decreased morbidity compared to open
surgery.6 However, liposuction has also been associated with a higher risk of nerve damage and a
higher recurrence rate. Lipomas with ﬁbrous capsule formation are likely to make liposuction more
difﬁcult.
Axillary lipomas are rare.5 De Andrade presented 31 cases of axillary masses, of which only one was
diagnosed as a lipoma.7 Symptoms localised to the axilla include pain, restrictedmovement of the arm,
stretching or compression of adjacent nerves and compartment syndrome.4
In our study, the patient's tumour had been present for approximately 35 years. It had not been
present at childhood, and he could not recollect any traumas associated with the occurrence of the
tumour. His sister had a lipoma removed from the posterior part of her neck, but to his knowledge no
other family members presented with lipomas.
Ideally, the patient should have undergone only one surgery, as the second surgerywas complicated
due to formation of scar tissue. The size as well as the location made open surgery the only possible
option. Due to the lipoma being present for many years, the brachial plexus was divided making total
removal of the lipoma almost impossible due to the risk of nerve damage, although a nerve stimulator
was used intraoperatively.
In conclusion, it is our opinion that the best treatment for giant axillary lipomas is open surgery. The
surgeon should be aware of anatomical changes in the axilla and displacement of vital structures, when
lipomas reach giant proportions and have been present for many years. A two-stage surgery procedure
is not advisable, and surgery should be performed by a skilled surgeon familiar with axillary lymph
node dissection. As it was impossible to remove the entire mass of the lipoma, the patient should be
followed up closely due to the risk of malignant transformation.
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